Healthcare - Biotechnology - NASDAQ - US
$ 0.3208
-11.5 %
$ 62.2 M
Market Cap
-0.15
P/E
Price Target
Average
3017.21%
Revenue Forecast
Estimate
100.96%
EBIT
Estimate
--18.46%
Net Income
Estimate
19.15%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
bluebird bio, Inc.
Wall Street analysts predict an average 1-year price target for BLUE of $10 , with forecasts ranging from a low of $5 to a high of $14 .
BLUE Lowest Price Target
Wall Street Target
5 USD
1458.60%
BLUE Average Price Target
Wall Street Target
10 USD
3017.21%
BLUE Highest Price Target
Wall Street Target
14 USD
4264.09%
REVENUE FORECAST
Revenue Forecast Chart BLUE
EBIT FORECAST
EBIT Forecast Chart BLUE
NET INCOME FORECAST
Net Income Chart BLUE